CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO I Deficiency NGS Genetic DNA Test
Introduction
The CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO I Deficiency NGS Genetic DNA Test is a cutting-edge diagnostic tool that plays a crucial role in identifying genetic mutations associated with hypoaldosteronism. This condition, characterized by low levels of the hormone aldosterone, can lead to severe metabolic disorders affecting electrolyte balance and blood pressure regulation. By utilizing Next Generation Sequencing (NGS) technology, this test provides a comprehensive analysis of the CYP11B2 gene, allowing for accurate diagnosis and informed medical decisions.
What the Test Measures
This genetic test specifically measures mutations in the CYP11B2 gene, which is responsible for the production of aldosterone. By analyzing the genetic sequences, healthcare providers can determine if an individual has inherited mutations that could lead to hypoaldosteronism.
Who Should Consider This Test
Individuals who may benefit from this test include:
- Those with a family history of hypoaldosteronism or related metabolic disorders.
- Patients exhibiting symptoms such as low blood pressure, fatigue, or electrolyte imbalances.
- Individuals undergoing genetic counseling for inherited conditions.
Benefits of Taking the Test
- Accurate diagnosis of genetic conditions affecting aldosterone production.
- Informed decision-making regarding treatment options and lifestyle adjustments.
- Enhanced understanding of family health history and potential risks for future generations.
- Access to specialized care from genetics professionals.
Understanding Your Results
Results from the CYP11B2 Gene Hypoaldosteronism test will provide insights into the presence of mutations in the CYP11B2 gene. A genetic counselor will help interpret the results, discuss implications for health management, and guide you on the next steps based on your results.
Test Pricing
| Discount Price | Regular Price |
|---|---|
| 400000 NGN | 560000 NGN |
Book Your Test
To ensure accurate testing, a clinical history and a genetic counseling session to draw a pedigree chart of family members affected with hypoaldosteronism congenital due to CMO I deficiency are required. The turnaround time for results is approximately 3 to 4 weeks.
Don’t wait to get the answers you need. Book your CYP11B2 Gene Hypoaldosteronism Congenital Due to CMO I Deficiency NGS Genetic DNA Test today! Call or WhatsApp us at +2348077798758 to schedule your appointment.
